Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Taxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials 3. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 4. 2008 Exclusive Survey—Earnings: Good news for primary care income 5. Paclitaxel plus bevacizumab versus paclitaxel alone for metastatic breast cancer
Top Ten Searches
post partum incontinence fibroid hpv colpotomy ovarian cyst curettage endometriosis intrauterine umbilical cordYour Article Summary
Current status of maintenance therapy for advanced ovarian cancer
International Journal of Women's Health, 11/03/09
Hope JM et al. – Even after countered with and responding to maximal surgical and chemotherapy efforts, advanced ovarian cancer usually ultimately recurs. One strategy employed to forestall recurrence is maintenance chemotherapy, an extension of treatment following a complete response to conventional measures. Many agents have been studied and many more are currently under investigation in maintenance regimens. While phase III data suggest that taxane maintenance prolongs progression–free survival, no overall survival benefit has been established. This article reviews the current status of maintenance therapy for advanced ovarian cancer, including phase III evidence and new and upcoming trials.
Related Articles
Accuracy of reporting current medications by cancer patients presenting to an emergency center
Supportive Care in Cancer, 11/11/09
Relevance Score: 88%
Medical Management of Ulcerative Colitis
Digestive Diseases, 11/09/09
Relevance Score: 87%
Ovarian epithelial tumors of low malignant potential: a case series of 5 adolescent patients
Journal of Pediatric Surgery, 10/26/09
Relevance Score: 80%
Is there a role for maintenance therapy in non-small-cell lung cancer? An emerging issue
Expert Review of Anticancer Therapy, 10/22/09
Relevance Score: 80%
Management of hypertension in the elderly patient
Clinical Interventions in Aging, 10/01/09
Relevance Score: 80%
Today in Clinical Pharmacology...keeping you current
Receive free subspecialty "5-minute updates" via email
Loss of HER2 Amplification Following Trastuzumab-Based Neoadjuvant Systemic Therapy and Survival Outcomes
Clinical Cancer Research, 11/20/09
Repeat Laparoscopic Paraaortic Lymphadenectomy for an Isolated Lymph Node Recurrence in a Patient with Stage IB2 Cervical Cancer
Journal of Minimally Invasive Gynecology, 11/20/09
Update on the efficacy, safety, and adherence to treatment of full length parathyroid hormone, PTH (1-84), in the treatment of postmenopausal osteoporosis
International Journal of Women's Health, 11/18/09
Today in Gynecologic Oncology...keeping you current
Receive free subspecialty "5-minute updates" via email
Laparoscopic Enucleation of a Bladder Leiomyoma
Journal of Minimally Invasive Gynecology, 11/20/09
Enhancing fraction measured using dynamic contrast-enhanced MRI predicts disease-free survival in patients with carcinoma of the cervix
British Journal of Cancer, 11/20/09
Evidence of measles virus antigens and RNA in endometrial cancer
European Journal of Obstetrics & Gynecology and Reproductive Biology , 11/20/09
Sponsor
Article Search
Sponsor


See Latest Articles


